Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Rifaximin SSD by Bausch Health for Hepatic Encephalopathy: Likelihood of Approval
Rifaximin SSD is under clinical development by Bausch Health and currently in Phase III for Hepatic Encephalopathy. According to GlobalData,...
Data Insights
Rifaximin SSD by Bausch Health for Sickle Cell Disease: Likelihood of Approval
Rifaximin SSD is under clinical development by Bausch Health and currently in Phase II for Sickle Cell Disease. According to...